BodyArmor impairment drags down Coca-Cola's Q4 GAAP operating profit by 32% year-on-year; full-year guidance falls short of expectations | Earnings Report Insight

BodyArmor impairment drags down Coca-Cola's Q4 GAAP operating profit by 32% year-on-year; full-year guidance falls short of expectations | Earnings Report Insight

```

Despite the continued strong performance of its zero-sugar series and slightly better-than-expected fourth-quarter results, Coca-Cola's 2026 growth guidance appears somewhat sluggish amid cooling inflation and waning pricing power, disappointing the market.

On February 10, global beverage giant Coca-Cola released its financial report for the fourth quarter and full year of 2025. The report showed that fourth-quarter revenue was $11.82 billion, a year-on-year increase of 2%, with organic revenue up 5%; comparable earnings per share (EPS) were $0.58, up 6% year-on-year and slightly above analysts' average expectations.

However, affected by a non-cash impairment charge of $960 million related to its acquired sports drink brand BodyArmor, fourth-quarter GAAP operating profit fell by 32% year-on-year.

The main point of intense market reaction lies in the company's outlook. Coca-Cola expects organic sales growth in 2026 to be between 4% and 5%, with the lower end of this guidance below Wall Street's average expectation of 5.01%. After years of growth driven by price increases, as consumers become more price-sensitive, investors worry this consumer giant's growth engine is slowing down.

Additionally, Coca-Cola faces an increasingly complex macro policy environment. On one hand, the Trump administration has delivered sharp signals regarding the unhealthy nature of carbonated drinks; on the other hand, some states in the U.S. are implementing new plans to restrict food aid recipients from purchasing soft drinks. Due to guidance falling short of expectations and macro concerns, Coca-Cola's stock price fell by as much as 4.1% in U.S. pre-market trading.

2026 Guidance Lags Expectations, Growth Normalizes

What worries investors most about this earnings report is the guidance for 2026. Coca-Cola expects organic revenue growth in 2026 to be 4% to 5%, whereas analysts previously expected an average growth above 5%. For earnings per share, the company expects comparable EPS to grow 7% to 8% on the basis of $3.00 in 2025 (including about 3% currency tailwind), indicating the company is transitioning from the "price increase boom" of the past high-inflation years to a more moderate growth norm.

Incoming CEO Henrique Braun faces the challenge that, as consumers shift from traditional high-calorie soft drinks to healthier options, the company must accelerate expansion into categories such as non-sugar beverages, sports drinks, and water. Although the company is optimistic about this shift, the lackluster guidance signals that management is cautious about the consumer environment in the coming year.

Fourth Quarter Results: Zero-Sugar Coke Still Biggest Highlight

Looking at the specific performance of the fourth quarter of 2025, Coca-Cola continued to show resilience in its core business, especially with the success of its "sugar-free" strategy:

  • Sales and Price: Global unit case volume grew 1%, price/mix grew 1%. This indicates the company maintained some pricing power amid a slight volume increase, though the extent of price hikes has narrowed significantly compared to previous years.
  • Category Performance: Coca-Cola Zero Sugar was once again the star product, with fourth-quarter sales surging 13% and full-year growth at 14%. In contrast, traditional full-sugar sodas faced pressure as consumer demand weakened. Diet Coke grew 2% in the fourth quarter and was flat for the year.
  • Other Categories: Water, sports drinks, coffee, and tea saw fourth-quarter sales grow 3%—a solid performance; however, juices, dairy, and plant-based drinks declined 3%, mainly due to drops in the Asia-Pacific and EMEA (Europe, Middle East, and Africa) regions.

BodyArmor "Blow-up", North America Profits Hit

Despite decent revenue, North America's profit side suffered a "black swan" event. The report showed that North America's fourth-quarter operating profit plummeted 65% year-on-year, mainly due to a $960 million non-cash impairment charge related to the BodyArmor trademark.

BodyArmor was an ambitious acquisition by Coca-Cola to catch up with Pepsi's Gatorade in the sports drink sector. However, this huge impairment suggests that the brand's performance after integration into Coca-Cola fell short of management's initial expectations, and fierce market competition forced the company to reassess this asset's value.

Excluding impairment and other one-offs, North America's fundamentals remain strong, with fourth-quarter unit case volume up 1%, price/mix up 4%, and comparable currency-neutral operating profit up 15%.

Besides financial metrics, Coca-Cola also subtly referenced external environmental challenges in its report. As consumer health awareness awakens, sugary beverages are facing headwinds.

Even more severe are policy pressures. Currently, some states in the U.S. have begun to restrict the use of food aid benefits to purchase soft drinks, directly impacting the spending power of low-income groups. Meanwhile, the Trump administration's recent tough stance on soda health issues could pose potential threats to brand image and long-term demand.

To meet these challenges, Coca-Cola is accelerating diversification of its product portfolio. The financial report shows the company is actively promoting innovative products like Powerade Power Water, and leveraging global sports events (such as South America's World Cup qualifiers) for marketing, attempting to strengthen sports and health attributes to offset the downside risks of traditional carbonated beverages.

Risk Warning and DisclaimerThe market has risks; investment requires caution. This article does not constitute individual investment advice and does not take into account specific investment goals, financial status, or needs of individual users. Users should consider whether any opinions, viewpoints, or conclusions in this article suit their particular situation. Investments based on this content are at your own risk. ```